{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:28:07Z","timestamp":1788222487457,"version":"build-2803163510"},"reference-count":95,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>As of 29 August 2023, a total of 89,596 confirmed cases of Mpox (monkeypox) have been documented across 114 countries worldwide, with 157 reported fatalities. The Mpox outbreak that transpired in 2022 predominantly affected young men who have sex with men (MSM). While most cases exhibited a mild clinical course, individuals with compromised immune systems, particularly those living with HIV infection and possessing a CD4 count below 200 cells\/mm3, experienced a more severe clinical trajectory marked by heightened morbidity and mortality. The approach to managing Mpox is primarily symptomatic and supportive. However, in instances characterized by severe or complicated manifestations, the utilization of antiviral medications becomes necessary. Despite tecovirimat\u2019s lack of official approval by the FDA for treating Mpox in humans, a wealth of positive clinical experiences exists, pending the outcomes of ongoing clinical trials. Brincidofovir and cidofovir have also been administered in select cases due to the unavailability of tecovirimat. Within the scope of this narrative review, our objective was to delve into the clinical attributes of Mpox and explore observational studies that shed light on the utilization of these antiviral agents.<\/jats:p>","DOI":"10.3390\/life13101969","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T03:04:18Z","timestamp":1695783858000},"page":"1969","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-9524","authenticated-orcid":false,"given":"Giuseppe","family":"Bruno","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, San Giuseppe Moscati Hospital, Azienda Sanitaria Locale Taranto, 74121 Taranto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Buccoliero","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, San Giuseppe Moscati Hospital, Azienda Sanitaria Locale Taranto, 74121 Taranto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.2022.12513","article-title":"The WHO declaration of monkeypox as a global public health emergency","volume":"328","author":"Nuzzo","year":"2022","journal-title":"JAMA"},{"key":"ref_2","first-page":"e26531","article-title":"Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation","volume":"14","author":"Kaler","year":"2022","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102362","DOI":"10.1016\/j.tmaid.2022.102362","article-title":"The never-ending global emergence of viral zoonoses after COVID-19? The rising concern of monkeypox in Europe, North America and beyond","volume":"49","author":"Pachar","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_4","unstructured":"(2023, August 29). World Health Organization. Available online: https:\/\/www.who.int\/emergencies\/situations\/monkeypox-oubreak-2022."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A Pox-like Disease in Cynomolgus Monkeys","volume":"46","author":"Magnus","year":"1959","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"ref_6","first-page":"165","article-title":"Human monkeypox, 1970\u20131979","volume":"58","author":"Breman","year":"1980","journal-title":"Bull. World Health Organ."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","article-title":"The eradication of smallpox\u2014An overview of the past, present, and future","volume":"29","author":"Henderson","year":"2011","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105794","DOI":"10.1016\/j.micpath.2022.105794","article-title":"Monkeypox virus: An emerging epidemic","volume":"173","author":"Aljabali","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shchelkunova, G.A., and Shchelkunov, S.N. (2022). Smallpox, monkeypox and other human orthopoxvirus infections. Viruses, 15.","DOI":"10.3390\/v15010103"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/fvl.12.130","article-title":"A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012","volume":"8","author":"Parker","year":"2013","journal-title":"Future Virol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ghosh, N., Chacko, L., Vallamkondu, J., Banerjee, T., Sarkar, C., Singh, B., Kalra, R.S., Bhatti, J.S., Kandimalla, R., and Dewanjee, S. (2023). Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks. Viruses, 15.","DOI":"10.3390\/v15071533"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/d41586-022-02178-w","article-title":"How does monkeypox spread? What scientists know","volume":"608","author":"Kozlov","year":"2022","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bunge, E.M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer, L.R., and Steffen, R. (2022). The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010141"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2200422","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200422","article-title":"Community transmission of monkeypox in the United Kingdom, April to May 2022","volume":"27","author":"Vivancos","year":"2022","journal-title":"Eurosurveillance"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.7326\/M22-2183","article-title":"Detection of Monkeypox Virus in Anorectal Swabs from Asymptomatic Men Who Have Sex with Men in a Sexually Transmitted Infection Screening Program in Paris, France","volume":"175","author":"Ferre","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e27993","DOI":"10.1002\/jmv.27993","article-title":"Monkeypox in a 71-year-old woman","volume":"95","author":"Bruno","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"ref_19","unstructured":"Isaacs, S.N., Friedman, H.M., and Kaplan, S.L. (2023, April 24). Vaccines to Prevent Smallpox, Mpox (Monkeypox), and Other Orthopoxviruses. Available online: https:\/\/medilib.ir\/uptodate\/show\/8296."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"109364","DOI":"10.1016\/j.intimp.2022.109364","article-title":"Poxviruses and the immune system: Implications for monkeypox virus","volume":"113","author":"Saghazadeh","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.maturitas.2022.07.018","article-title":"Monkeypox in the elderly: Is an unwelcome surprise to be expected?","volume":"164","author":"Bruno","year":"2022","journal-title":"Maturitas"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1473-3099(22)00411-X","article-title":"Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: An observational analysis","volume":"22","author":"Girometti","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: A prospective observational cohort study","volume":"400","author":"Alemany","year":"2022","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e28534","DOI":"10.1002\/jmv.28534","article-title":"Transmission of monkeypox\/mpox virus: A narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak","volume":"95","author":"Pan","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","article-title":"Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention","volume":"33","author":"Petersen","year":"2019","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cmi.2022.08.012","article-title":"Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: An observational cohort study","volume":"29","author":"Mailhe","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zong, Y., Kamoi, K., Zhang, J., Yang, M., and Ohno-Matsui, K. (2023). Mpox (Monkeypox) and the Eye: Ocular Manifestation, Diagnosis, Treatment and Vaccination. Viruses, 15.","DOI":"10.3390\/v15030616"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/bjd.21790","article-title":"Monkeypox outbreak in Spain: Clinical and epidemiological findings in a prospective cross-sectional study of 185 cases","volume":"187","author":"Castells","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/03007995.2023.2200122","article-title":"Comparison of human monkeypox, chickenpox and smallpox: A comprehensive review of pathology and dermatological manifestations","volume":"39","author":"Rasizadeh","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e27931","DOI":"10.1002\/jmv.27931","article-title":"Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review","volume":"95","author":"Bragazzi","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e27902","DOI":"10.1002\/jmv.27902","article-title":"Re-emerging human monkeypox: A major public-health debacle","volume":"95","author":"Saxena","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"ofac557","DOI":"10.1093\/ofid\/ofac557","article-title":"Human monkeypox in people with HIV: Transmission, clinical features, and outcome","volume":"9","author":"Casado","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"849.e7","DOI":"10.1016\/j.ajog.2022.08.017","article-title":"Monkeypox in pregnancy: Virology, clinical presentation, and obstetric management","volume":"227","author":"Dashraath","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1178654","DOI":"10.3389\/fpubh.2023.1178654","article-title":"Variations in national surveillance reporting for Mpox virus: A comparative analysis in 32 countries","volume":"11","author":"Panag","year":"2023","journal-title":"Front. Public Health"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"ref_36","first-page":"297","article-title":"Human monkeypox: Confusion with chickenpox","volume":"45","author":"Jezek","year":"1988","journal-title":"Acta Trop."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: Clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e28229","DOI":"10.1002\/jmv.28229","article-title":"Monkeypox treatment: Current evidence and future perspectives","volume":"95","author":"Khani","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1157670","DOI":"10.3389\/fmed.2023.1157670","article-title":"Human monkeypox: History, presentations, transmission, epidemiology, diagnosis, treatment, and prevention","volume":"10","author":"Zahmatyar","year":"2023","journal-title":"Front. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.12688\/f1000research.130272.2","article-title":"Monkeypox (mpox) in immunosuppressed patients","volume":"12","author":"Ahmed","year":"2023","journal-title":"F1000Research"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17460441.2023.2199980","article-title":"The discovery of novel antivirals for the treatment of mpox: Is drug repurposing the answer?","volume":"18","author":"Ezat","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Chiem, K., Nogales, A., Lorenzo, M., Morales Vasquez, D., Xiang, Y., Gupta, Y.K., Blasco, R., de la Torre, J.C., and Mart\u00ednez-Sobrido, L. (2023). Identification of In Vitro Inhibitors of Monkeypox Replication. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.04745-22"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cid\/ciac622","article-title":"Antivirals with Activity Against Mpox: A Clinically Oriented Review","volume":"76","author":"Siegrist","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","article-title":"An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications","volume":"19","author":"Russo","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e0122622","DOI":"10.1128\/aac.01226-22","article-title":"New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus","volume":"66","author":"DeLaurentis","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/fvl.11.27","article-title":"Development of the small-molecule antiviral ST-246 as a smallpox therapeutic","volume":"6","author":"Grosenbach","year":"2011","journal-title":"Future Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral Tecovirimat for the Treatment of Smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1128\/AAC.00208-15","article-title":"Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection","volume":"59","author":"Berhanu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2007.76.768","article-title":"Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection","volume":"76","author":"Sbrana","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: Determination of the minimal effective dose and human dose justification","volume":"53","author":"Jordan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Sudarmaji, N., Kifli, N., Hermansyah, A., Yeoh, S.F., Goh, B.-H., and Ming, L.C. (2022). Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies. Viruses, 14.","DOI":"10.3390\/v14112496"},{"key":"ref_52","unstructured":"(2023, August 30). FDA Approves First Smallpox-Indicated Treatment, SIGA\u2019s TPOXX. Available online: https:\/\/www.genengnews.com\/topics\/drug-discovery\/fda-approves-first-smallpox-indicated-treatment-sigas-tpoxx\/."},{"key":"ref_53","unstructured":"Centers for Disease Control and Prevention (2023, August 25). Guidance for Tecovirimat Use: Expanded Access Investigational New Drug Protocol during 2022 US Monkeypox Outbreak, Available online: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/Tecovirimat."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/S1473-3099(22)00722-8","article-title":"D\u00e9j\u00e0 vu all over again? Monkeypox and the urgent need for randomised controlled trials","volume":"23","author":"Lindholm","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries\u2014April\u2013June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Hermanussen, L., Brehm, T.T., Wolf, T., Boesecke, C., Schlabe, S., Borgans, F., Monin, M.B., Jensen, B.O., Windhaber, S., and Scholten, S. (2023). Tecovirimat for the treatment of severe Mpox in Germany. Infection.","DOI":"10.1007\/s15010-023-02049-0"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e28825","DOI":"10.1002\/jmv.28825","article-title":"Rapid improvement of severe Mpox lesions with oral tecovirimat","volume":"95","author":"Raccagni","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jama.2022.15336","article-title":"Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection","volume":"328","author":"Desai","year":"2022","journal-title":"JAMA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"ofac377","DOI":"10.1093\/ofid\/ofac377","article-title":"Tecovirimat for the Treatment of Human Monkeypox: An Initial Series from Massachusetts, United States","volume":"9","author":"Matias","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e28868","DOI":"10.1002\/jmv.28868","article-title":"Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox","volume":"95","author":"Mazzotta","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"642","DOI":"10.7326\/M22-3132","article-title":"Tecovirimat Treatment of People with HIV During the 2022 Mpox Outbreak: A Retrospective Cohort Study","volume":"176","author":"McLean","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"Mpox in people with advanced HIV infection: A global case series","volume":"401","author":"Alemany","year":"2023","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e0056823","DOI":"10.1128\/aac.00568-23","article-title":"Identification of Tecovirimat Resistance-Associated Mutations in Human Monkeypox Virus\u2014Los Angeles County","volume":"67","author":"Garrigues","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.7326\/L23-0131","article-title":"Tecovirimat Resistance in an Immunocompromised Patient with Mpox and Prolonged Viral Shedding","volume":"176","author":"Mertes","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Higgins, E., Ranganath, N., Mehkri, O., Majeed, A., Walker, J., Spivack, S., Bhaimia, E., Benamu, E., Hand, J., and Keswani, S. (2023). Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: A multicenter case series and literature review. Am. J. Transplant.","DOI":"10.1016\/j.ajt.2023.07.016"},{"key":"ref_66","first-page":"CD015769","article-title":"Therapeutics for treating mpox in humans","volume":"3","author":"Fox","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Imran, M., Alshammari, M.K., Arora, M.K., Dubey, A.K., Das, S.S., Kamal, M., Alqahtani, A.S.A., Sahloly, M.A.Y., Alshammari, A.H., and Alhomam, H.M. (2023). Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020278"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1128\/AAC.02814-14","article-title":"In vitro efficacy of brincidofovir against variola virus","volume":"58","author":"Olson","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/421912","article-title":"Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection","volume":"190","author":"Bidanset","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e01683-19","DOI":"10.1128\/AAC.01683-19","article-title":"Drug development against smallpox: Present and future","volume":"64","author":"Delaune","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2217\/fmb-2019-0288","article-title":"Brincidofovir: Understanding its unique profile and potential role against adenovirus and other viral infections","volume":"15","author":"Whited","year":"2020","journal-title":"Future Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"105182","DOI":"10.1016\/j.antiviral.2021.105182","article-title":"Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration\u2019s Evaluation","volume":"195","author":"Harrington","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"102528","DOI":"10.1016\/j.tmaid.2022.102528","article-title":"Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf","volume":"52","author":"Jiang","year":"2023","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"NHS England High Consequence Infectious Diseases (Airborne) Network. Clinical features and management of human monkeypox: A retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"232","DOI":"10.15585\/mmwr.mm7209a4","article-title":"Interim Clinical Treatment Considerations for Severe Manifestations of Mpox\u2014United States, February 2023","volume":"72","author":"Rao","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","year":"2002","journal-title":"Antivir. Res."},{"key":"ref_77","first-page":"1561","article-title":"Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients","volume":"3","author":"Snoeck","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1517\/14656566.2015.1083975","article-title":"New drug on the horizon for treating adenovirus","volume":"16","author":"Wold","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00042560-199700001-00005","article-title":"Cidofovir: A new therapy for cytomegalovirus retinitis","volume":"14","author":"Lalezari","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(02)00198-5","article-title":"In vitro activity of potential anti-poxvirus agents","volume":"57","author":"Kern","year":"2003","journal-title":"Antiv. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jinf.2022.11.001","article-title":"Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital","volume":"86","author":"Mondi","year":"2023","journal-title":"J. Infect."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e28218","DOI":"10.1002\/jmv.28218","article-title":"Real-life use of cidofovir for the treatment of severe monkeypox cases","volume":"95","author":"Raccagni","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s15010-022-01949-x","article-title":"Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome","volume":"51","author":"Fabrizio","year":"2023","journal-title":"Infection"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1473-3099(23)00044-0","article-title":"Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection","volume":"23","author":"Stafford","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"102417","DOI":"10.1016\/j.tmaid.2022.102417","article-title":"Hospitalisation for monkeypox in Milan, Italy","volume":"49","author":"Moschese","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ced\/llac038","article-title":"Monkeypox: Is topical cidofovir a good idea?","volume":"48","year":"2023","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1097\/MS9.0000000000000550","article-title":"Mpox vaccination in global perspective: Priorities and challenges","volume":"85","author":"Rana","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm1265","article-title":"Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases","volume":"11","author":"Reeves","year":"2005","journal-title":"Nat. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2012.02.012","article-title":"Orthopoxvirus targets for the development of new antiviral agents","volume":"94","author":"Prichard","year":"2012","journal-title":"Antiv. Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Lam, H.Y.I., Guan, J.S., and Mu, Y. (2022). In Silico repurposed drugs against mpoxvirus. Molecules, 27.","DOI":"10.1101\/2022.07.17.500371"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e28306","DOI":"10.1002\/jmv.28306","article-title":"Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies","volume":"95","author":"Rabaan","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11671-008-9128-2","article-title":"A preliminary assessment of silver nanoparticle inhibition of mpox virus plaque formation","volume":"3","author":"Rogers","year":"2008","journal-title":"Nanoscale Res. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: State of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1743-422X-6-188","article-title":"Inhibition of Mpox virus replication by RNA interference","volume":"6","author":"Alkhalil","year":"2009","journal-title":"Virol. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/14728222.2023.2230361","article-title":"Potential therapeutic targets for Mpox: The evidence to date","volume":"27","author":"Byrareddy","year":"2023","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/10\/1969\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:58:59Z","timestamp":1760129939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/10\/1969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":95,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["life13101969"],"URL":"https:\/\/doi.org\/10.3390\/life13101969","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]}}}